Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

NCT03598257 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

300

Enrollment

NIH

Sponsor class

Conditions

Breast Inflammatory Carcinoma

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Olaparib
RADIATION: Radiation Therapy
OTHER: Survey Administration

Sponsor

National Cancer Institute (NCI)